Background: Regulated secretion by mast cells is known to be controlled by GTP-binding proteins, but the proteins involved have not been identified. Rac and Rho, two small GTPases related to the oncoprotein Ras, mediate transmission of signals from cell-surface receptors to the actin cytoskeleton. In rat mast cells, both Rac and Rho participate in effecting the centripetal redistribution of filamentous actin that is observed after stimulation of the cells. Rho is responsible for polymerization of actin filaments in the cell interior, whereas Rac is required for the entrapment in the interior of filaments released from the cortex. Such cytoskeletal changes could be important in control of the exocytotic process, so we examined whether Rac and Rho also play a role in regulated secretion by mast cells. Results: We show that the constitutively active mutant proteins, V14RhoA and V12Racl, enhance regulated secretion from permeabilized mast cells by increasing the proportion of cells that are competent to respond to stimulation. In addition, inhibition of endogenous Rac and Rho activity using inhibitors, N17Racl and C3 transferase, respectively, reduces the secretory response of mast cells to stimuli. Conclusion: These results provide direct evidence that, in mast cells, both Rac and Rho are components of the signalling pathway that leads to secretion.
Background
The activation of a cell's surface receptors is usually accompanied by changes in the organization of the cytoskeleton. Microinjection studies with cultured fibroblasts have shown that the transmission of signals from cell-surface receptors to the actin cytoskeleton is mediated by the small GTPases Rac and Rho, which are related to the oncoprotein Ras. Rac and Rho are essential for the assembly of stress fibres and membrane ruffles, respectively [1, 2] . Rac has also been shown to be an essential component of a multi-protein complex required for the activation of NADPH oxidase in phagocytic leukocytes, a function that seems to be independent of the cytoskeleton [3, 4] . Rho has been implicated in the regulation of smooth muscle contraction [5] and cytoplasmic division [6] , in thrombin-induced aggregation of platelets [7] , and in the aggregation of lymphocytes that is induced by the phorbol ester phorbol myristate acetate [8] . Recently, phosphatidylinositide 3-kinase has been suggested to be both downstream [9, 10] and upstream [11] of Rho-related proteins. Interestingly, in rat basophilic leukemia (RBL-2H3) cells, inhibition of the activity of phosphatidylinositide 3-kinase by wortmannin led to a profound reduction in histamine secretion [12] .
The cytoskeleton of mast cells
Our previous work implicated Rac and Rho in regulating the organization of the actin cytoskeleton in mast cells [13] . Addition of the slowly hydrolyzable GTP analogue, GTP-y-S, to permeabilized cells resulted in a reorganization of actin filaments: the content of filamentous (F) actin was reduced in the cortical region and increased in the cell interior. AF4-, an activator of heterotrimeric G proteins [14] , induced disassembly of F-actin at the cell cortex, whereas the appearance of actin filaments in the interior of the cell was dependent on Rac and Rho. Rho was found to be responsible for de novo actin polymerization, and Rac was found to be required for the entrapment in the cell interior of actin filaments released from the cortex. These rearrangements were independent of Ca 2 +, although Ca 2 + causes a substantial reduction in the F-actin content of permeabilized mast cells, independently of GTP-y-S [15] .
Analysis of Rac and Rho function
It has been possible to examine the role of Rac and Rho in other cellular responses by using recombinant Rac and Rho proteins, together with inhibitors of the endogenous proteins [1, 2, 13] . We have used the constitutively activated Rac and Rho proteins, V12Racl and V14RhoA, in which the glycines at residue 12 in Racl, and residue 14 in RhoA, respectively, have been replaced by valines. These mutant proteins are thus equivalent to the Vall2 oncogenic mutant form of Ras: they have decreased intrinsic GTPase activity, and are unresponsive to GTPase-activating proteins (GAPs) ' [16, 17] . An inactive form of Rac, V12A35Racl, in which the threonine at residue 35 has been replaced by alanine in a version of the protein that also has the Vall2 mutation, was used as a control [2] . Rho function was inhibited with C3 transferase, an exoenzyme from Clostridium botulinum, which inactivates Rho by ADP-ribosylating it on asparagine residue 41 [18] [19] [20] . Finally, a dominantinhibitory Rac protein, N17Racl, was used to inhibit the activity of endogenous Rac proteins [2] . By analogy to the activity of N17Ras, N17Racl may act by competitively inhibiting the interaction of endogenous Rac proteins with guanine-nucleotide exchange factors [21, 22] . [24] , and Rab3a [25] , a small GTPase of the Rab family -may be involved. Recent work, however, indicates that Rab3a is actually a negative regulator of exocytosis in chromaffin cells [26] .
GTP-binding proteins and mast cells
In the study reported here, we examine the effects on secretion of recombinant Rac and Rho proteins. We show that both proteins enhance the secretory response in mast cells by increasing the proportion of responding cells, whereas inhibiting endogenous Rac and Rho leads to reduced secretion.
Results and discussion
Exogenous Rac and Rho enhance secretion from permeabilized mast cells In various combinations, Ca 2 +, guanine nucleotides and ATP can elicit a secretory response from permeabilized rat mast cells. The extent of secretion varies greatly, and depends on the state of the cells [27] [28] [29] . In Figures la and lb, control bars show the levels of secretionmeasured by hexosaminidase release as a percentage of the total hexosaminidase content -obtained after stimulation with either GTP-y-S in the absence of Ca 2+ , or Ca 2 + (pCa 4.75) in the absence of added guanine nucleotide. Addition of the constitutively active mutants V14RhoA (Fig. la, bars (pCa 4.75), 3 mM Mg-ATP (right-hand bars in (a) and (b); also in (c)) and the released hexosaminidase was assayed as described in Materials and methods. During stimulation, the final concentrations of all proteins were reduced by a factor of 2/3. Base-line secretion, from cells exposed to 3 mM EGTA, was 4 %. The results are representative of at least three different experiments.
The enhancement of Ca 2 +-induced secretion by addition of Rac and Rho was significant for each protein as determined by a paired t-test (Table 1) . GTP--y-S-induced secretion was enhanced to a much smaller extent, and this increase was only marginally significant. Figure c shows the dependence of the Ca 2 +-induced response on the dose of V14RhoA or V12Racl. Again, there was no response to V12A35Racl, even at a high concentration (32 g ml-1). The EC 50 for each protein was 4-8 p,.g ml-1, although there were some variations with different batches of protein. No additive effects of V14RhoA and V12Racl were seen when the proteins were used together at near-saturating concentrations (data not shown).
Exogenous Rac and Rho enhance the proportion of cells that degranulate in response to Ca

2+
The extent of secretion was also evaluated by studying the proportion of cells that changed their light-scattering characteristics as a consequence of degranulation ( Fig. 2a-d ) [30] . Only one cell population was visible in control cells (cells exposed to EGTA; Fig. 2a) , and most of the cells were contained in region X of the light-scatter plot. In response to Ca 2+ and ATP, two populations became apparent, in regions Y and Z of the plot (Fig. 2b) . These two populations contained non-secreting and secreting cells, respectively, as confirmed by their staining with FITC-succinyl-Concanavalin A. (This fluorescent lectin binds to granular glycoproteins and proteoglycans that are exposed following degranulation of mast cells; L.S.P, J.C.N. and A.K, unpublished observations) The non-secreting population found in region Y differs from the control population in region X by its reduced content of filamentous actin (L.S.P. and A.K., unpublished observations). Ca 2 + and ATP induced about 40 % of cells to enter region Z -that is, to degranulate; this proportion increased to 65 % when 8 g ml-' of V12Racl was added (Fig. 2c) and to 85 % with 16R1gml-1 of V12Racl (Fig. 2d) . Thus, the effect of V12Racl is to increase secretion by increasing the number of cells competent to respond to Ca 2+ and ATP With concentrations of added V12Racl increasing from 0-32 ,ug ml-1, the proportion of degranulating cells increased from 43-85 % (Fig. 2e) . Similar experiments with V14RhoA have shown that it too greatly enhanced the 'number of cells that responded to Ca 2+ and ATP (data not shown).
Inhibition of endogenous Rac and Rho reduces secretion
Specific inhibitors of Rac and Rho were used to study the involvement of the endogenous proteins in the secretory response. Figure 3 shows the effects of inhibiting Rho by C3 transferase (left bars), and Rac by a dominant-inhibitory Rac protein, N17Racl (right bars), on the secretion induced by GTP-y-S in the presence of Mg-ATP (GA in Fig. 3) , and by Ca 2+ in the presence of Mg-ATP (CA in Fig. 3 ). Inhibition of Rho by C3 transferase reduced both responses. The inhibitory effect of C3 transferase (seen at concentrations of the enzyme from 0.1 plg ml -t upwards) was very pronounced, and co-addition of N17Racl caused only a small increase (-10 %) in this inhibition. Inhibition of Rac by N17Racl gave somewhat different results. N17Racl clearly inhibited the response to GTP-'y-S, but only marginally reduced the response to Ca 2+ . These results indicate that both endogenous proteins participate in the response to GTP-'y-S, but only Rho is important for secretion induced by Ca 2+ in the absence of added guanine nucleotide. The possibility that an endogenous activated Rac, which is already in the GTP-bound form, participates in the response to Ca 2 + cannot be entirely excluded, however. Such an activated Rac would not require any guanine-nucleotide exchange factor and would therefore be unaffected by N17Racl [21, 22] .
The presence of Rac and Rho in mast cells
Endogenous Rac and Rho proteins are present in rat mast cells (Fig. 4) . The cells contained a substrate for C3 transferase, and most of the total C3 substrate remained in the cells after permeabilisation ( Fig. 4a ; [13] ). Similar results were obtained by western immunoblotting with a polyclonal antiserum raised against recombinant Rho protein (Fig. 4b) ; this shows about 30 % leakage of the protein as estimated by densitometry of blots. The presence of Rac Methods as in (b). V14RhoA (6 and 30 ng; total protein concentration) and V12Racl (10 and 50 ng; total protein concentration) were used as standards. There was no cross-reactivity between anti-Rho antibodies and V12Rac (b), but there was some cross-reactivity between anti-Rac antibodies and V14RhoA (c).
is shown on the immunoblot in Figure 4c ; the proportion of Rac that leaked out of permeabilized cells was about 32 %. Taken together, the results shown in Figure 4 provide evidence that both Rac and Rho are expressed in mast cells and that a major portion of both proteins remains associated with intracellular structures after cell permeabilization. Using the recombinant proteins as standards, crude estimates were made of the intracellular content of Rho and Rac. On the basis of the blots shown in Figures 4b and 4c , about 27.5 ng of Rho and 11 ng of Rac were present per 106 cells. This represents about 1 ,uM Rho and 0.4 ,uM Rac when extrapolated to intact cells (cell volume is -1.3 picolitre). This concentration for Rho is approximately in agreement with our previous estimate (0.3 ,uM) on the basis of the presence of a C3 substrate in cells [13] .
Materials and methods
To our knowledge, the work described here is the first demonstration, using a reconstitution approach, that a specific, intact, GTP-binding protein stimulates regulated exocytosis. In addition, it defines a new function for the two small GTPases, Rac and Rho. We have previously shown that these two proteins have distinct functions in regulating actin organization in mast cells; the cytoskeletal responses mediated by Rac and Rho are independent [13] . Here, we show that both proteins regulate the secretory response of mast cells, indicating that Rac and Rho may either communicate or share the same downstream target in the signalling pathway that leads to secretion. This suggestion is consistent with studies showing that Rac and Rho interact with overlapping sets of proteins in vitro [17, [31] [32] [33] .
It is possible that the effects of Rac and Rho on secretion may be a consequence of their cytoskeletal effects. Our preliminary experiments suggest that these two signalling pathways are divergent, however, as the two activities can be separated; the secretory response can be induced in the absence of the cytoskeletal effects, and vice versa (our unpublished observations). The model shown in Figure 5 summarizes these possibilities. Ca 2 + has not been included in this model, but is most probably relevant to both cytoskeletal and secretory responses [15, 27] . The interdependence of the signalling pathways that regulate the cytoskeletal and secretory effects and the relevance of actin reorganization to exocytosis remain to be established.
Fig 5.
A model for the regulation of actin organization and exocytosis by Rac and Rho. Receptor stimulation leads to activation of Rac and Rho, causing relocalization of released cortical filaments and de novo actin polymerization, respectively. The activity of Rac and/or Rho is also necessary for exocytotic fusion. The signalling pathways leading to the cytoskeletal and secretory responses may be parallel -with Rac and Rho communicating and/or sharing the same down-stream target(s) in the signalling pathway to secretion, although they act independently on the cytoskeleton -or in series, with secretion consequent on the cytoskeletal effects of Rac and Rho, or synergistic, with the cytoskeletal changes amplifying the secretory response.
Materials
All nucleotides (GTP-y-S, GDP-3-S, GTP and ATP) were obtained from Boehringer Mannheim. Streptolysin-O (SL-O) was from Murex Diagnostics Ltd (Cat. MRI6, Lot K 809810). V12Racl, V12A35Racl, N17Racl and V14RhoA proteins were purified as glutathione-S-transferase-fusion proteins, subsequently cleaved and characterized as described [2] . With the exception of N17Racl, GTP was bound to the proteins before their dialysis, ensuring the removal of free GTP. Active protein concentrations were determined by a filter binding assay using [ 3 H]GDP [34] . Concentrations of active proteins were used for all experiments except immunoblots (Fig. 4b,c) , for which total protein concentrations were used. C3 transferase was a kind gift from A. Hall. All other reagents were obtained from the Sigma Chemical Company, Poole, Dorset, UK.
Cells and secretion assays
Rat peritoneal mast cells were prepared as described previously [23] , permeabilized for 2 minutes at 30 C in a glutamate-based buffer (GB: 137 mM sodium glutamate, 2 mM MgC1 2 , 1 mg m1-1 BSA, 20 mM sodium Pipes, pH 6.8) containing 3 mM EGTA and SL-O (0.4 IU ml-1), and finally washed in GB as described [29] . Where indicated, cells in 100 p.M EGTA-GB were preincubated at room temperature for specified times with V14RhoA, V12Racl, V12A35Racl, N17Racl or with C3 transferase and NAD + . After these preincubations, cells were stimulated for 30 minutes at 30 °C with various combinations of GTP-y-S, Ca 2+ and Mg-ATP. Ca 2+ was buffered by 3 mM Ca 2 +-EGTA buffer, pH 6.8, using appropriate dissociation constants [35] . The time between permeabilisation and stimulation was 14-20 minutes. Released hexosaminidase was assayed as described previously [23] .
Flow cytometry
Permeabilized mast cells were preincubated with various proteins, stimulated as above, fixed in 1 % formaldehyde in GB and their forward angle (1.5-19°) and 900 light-scatter analyzed with an EPICS Elite flow cytometer (Coulter Electronics Inc., Hialeah, Florida, USA). The presence of non-secreting and secreting cells in specific sub-populations was confirmed by staining (before fixation) of the exposed granule glycoproteins with FITC-succinyl-Concanavalin A (64 pg ml-1). Each sample contained at least 10 000 cells.
The presence of Rho as a substrate for C3 transferase
Mast cells were treated with SL-O (0.8 IU ml -1) for 5 minutes on ice (at this temperature, no permeabilization occurs), centrifuged at 4 C, then resuspended in aliquots (250 000 cells in 200 R1) in GB containing protease inhibitors. Permeabilization was initiated by incubating the cells at 30 C. After 10 minutes (to allow permeabilization and leakage), cells -with the exception of the 'total' sample -were centrifuged (1 minute at 12000 x g). The supernatant was removed and the pellet resuspended in 200 ,al of GB and the three samples were incubated for 20 min at room temperature with C3 transferase (0.1 Ig ml-1) and 3.7 LzCi [ 32 P]NAD (2.5 RIM). Proteins were then precipitated by addition of 25 p 1 l 100 % trichloroacetic acid (TCA; 30 minutes on ice), pelleted (2 minutes at 1200xg), washed twice with ethanol-ether (1:1), dissolved in 50 p.1 of Laemmli sample buffer [36] and analyzed on a 12.5 % SDS-polyacrylamide gel. The gel was dried and the labelled proteins were visualized using phosphor-imaging plates and Bio-Imaging Analyser FUJIX BAS 1000.
Conclusions
Western immunoblotting
Mast cells were permeabilised as above and centrifuged after 10 min. The pellets were resuspended in 200 .1L GB and, together with the 'total' samples and the supernatants, treated for 5 min on ice with 0.5 % Triton X-100 and centrifuged (5 min at 10 000 x g) to pellet nuclei. Proteins were then dissolved in sample buffer, analyzed by SDS-gel electrophoresis as above, transferred to nitrocellulose and probed [37] with polyclonal antibodies (1/1000) raised against recombinant Rho and Rac proteins [33] .
